The reporting quality, scientific rigor, and ethics of randomized placebo-controlled trials of traditional Chinese medicine compound formulations and the differences between Chinese and non-Chinese trials

Current Therapeutic Research - Clinical and Experimental

Volumn 71, Issue 1, 2010, Pages 30-49

  Zhong, Yun Qing ^a   Fu, Juan Juan ^a   Liu, Xue Mei ^a   Diao, Xiang ^a   Mao, Bing ^a   Fan, Tao ^a   Yang, Hong Mei ^a   Liu, Guan Jian ^a   Zhang, Wen Bin ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

CONSORT statement; ethics; placebo; randomized controlled trial; reporting quality; scientific rigor; traditional Chinese medicine compound formulation

Indexed keywords

EID: 82455177167     PISSN: 0011393X     EISSN: 18790313     Source Type: Journal    
DOI: 10.1016/j.curtheres.2010.02.001     Document Type: Review

References (36)

1. Welch, WH, The interdependence of medicine and other sciences of nature. Science. 27 (1908), 49–64.
2. Lewith, GT, Complementary and alternative medicine: An educational, attitudinal and research challenge. MedJ Aust. 172 (2000), 102–103.
3. Chou, PB, Morse, CA, Xu, H, A controlled trial of Chinese herbal medicine for premenstrual syndrome. J Psychosom Obstet Gynaecol. 29 (2008), 185–192.
4. Farag, NH, Mills, PJ, A randomised-controlled trial of the effects of a traditional herbal supplement on sleep onset insomnia. Complement Ther Med. 11 (2003), 223–225.
5. Wen, MC, Wei, CH, Hu, ZQ, et al. Efficacy and tolerability of anti-asthma herbal medicine intervention in adult patients with moderate-severe allergic asthma. J Allergy Clin Immunol. 116 (2005), 517–524.
6. Winther, K, Hedman, C, Assessment of the effects of the herbal remedy femal on the symptoms of premenstrual syndrome: A randomized, double-blind, placebo-controlled study. Curr Ther Res Clin Exp. 63 (2002), 344–353.
7. Lao, L., Traditional Chinese medicine. Jonas, WB, Levin, JS, (eds.) Essentials of Complementary and Alternative Medicine, 1999, Williams & Wilkins, Baltimore, Md, 216–232.
8. Jiao, ZL, Exploitation and research of traditional Chinese medicine compound prescriptions. Shaanxi J Traditional Chinese Med. 25 (2004), 357–359.
9. Yu, F, Takahashi, T, Moriya, J, et al. Traditional Chinese medicine and Kampo: A review from the distant past for the future. J Int Med Res. 34 (2006), 231–239.
10. Leung, KF, Liu, FB, Zhao, L, et al. Development and validation of the Chinese Quality of Life Instrument. Health Qual Life Outcomes., 3, 2005, 26.
11. Park, J, Park, HJ, Lee, HJ, Emst E. What's in a name? A systematic review of the nomenclature of Chinese medical formulae. Am J Chin Med. 30 (2002), 419–427.
12. Qi, GD, We, DA, Chung, LP, Fai, CK, Placebos used in clinical trials for Chinese herbal medicine. Recent Pat Inflamm Allergy Drug Discov. 2 (2008), 123–127.
13. Tang, XD, Bian, LQ, Gao, R, et al. Exploration into the preparation of placebos used in Chinese medicinal clinical trial [in Chinese]. Zhongguo Zhong Xi Yi Jie He Za Zhi. 29 (2009), 656–658.
14. Gagnier, JJ, DeMelo, J, Boon, H, et al. Quality of reporting of randomized controlled trials of herbal medicine interventions. Am J Med. 119 (2006), 800.e1–800.e11.
15. Wang, G, Mao, B, Xiong, ZY, et al. The quality of reporting of randomized controlled trials of traditional Chinese medicine: A survey of 13 randomly selected journals from mainland China. Clin Ther. 29 (2007), 1456–1467.
16. Moher, D, Schulz, KF, Altman, D, CONSORT (Consolidated Standards of Reporting Trials) Group. The CONSORT statement: Revised recommendations for improving the quality of reports of parallel-group randomized trials. JAMA. 285 (2001), 1987–1991.
17. Begg, C, Cho, M, Eastwood, S, et al. Improving the quality of reporting of randomized controlled trials. The CONSORT statement. JAMA. 276 (1996), 637–639.
18. Du, L, Chen, YL, Chen, M, et al. From CONSORT to GCP: An introduction to good publication practice. Acta Editologica. 20 (2008), 367–370.
19. Gagnier, JJ, Boon, H, Rochon, P, et al., CONSORT (Consolidated Standards of Reporting Trials) Group. Recommendations for reporting randomized controlled trials of herbal interventions: Explanation and elaboration. J Clin Epidemiol. 59 (2006), 1134–1149.
20. Moher, D, Jones, A, Lepage, L, CONSORT (Consolidated Standards of Reporting Trials) Group. Use of the CONSORT statement and quality of reports of randomized trials: A comparative before-and-after evaluation. JAMA. 285 (2001), 1992–1995.
21. Wu, TX, Li, YP, Bian, ZX, et al. Consolidated standards for reporting trials of traditional Chinese medicine (CONSORT for TCM). Chin J EBM. 7 (2007), 625–630.
22. Altman, DG, Schulz, KF, Moher, D, et al., CONSORT (Consolidated Standards of Reporting Trials) Group. The revised CONSORT statement for reporting randomized trials: Explanation and elaboration. Ann Intern Med. 134 (2001), 663–694.
23. Vickers, AJ, de Craen, AJ, Why use placebos in clinical trials? A narrative review of the methodological literature. J Clin Epidemiol. 53 (2000), 157–161.
24. Council for International Organizations of Medical Sciences. International ethical guidelines for biomedical research involving human subjects. Bull Med Ethics, 2002, 17–23.
25. Banerjee, M, Capozzoli, M, McSweeney, L, Sindha, D, Beyond kappa: A review of interrater agreement measures. Can J Stat. 27 (1999), 3–23.
26. Huwiler-Muntener, K, Jüni, P, Junker, C, Egger, M, Quality of reporting of randomized trials as a measure of methodologic quality. JAMA. 287 (2002), 2801–2804.
27. Linde, K, Jonas, WB, Melchart, D, Willich, S, The methodological quality of randomized controlled trials of homeopathy, herbal medicines and acupuncture. Int J Epidemiol. 30 (2001), 526–531.
28. Zwarenstein, M, Treweek, S, Gagnier, JJ, et al., CONSORT (Consolidated Standards of Reporting Trials) Group and the Pragmatic Trials in Healthcare (Practihc) Group. Improving the reporting of pragmatic trials: An extension of the CONSORT statement. BMJ., 337, 2008, a2390.
29. Devereaux, PJ, Manns, BJ, Ghali, WA, et al. Physician interpretations and textbook definitions of blinding terminology in randomized controlled trials. JAMA. 285 (2001), 2000–2003.
30. Fergusson, D, Glass, KC, Waring, D, Shapiro, S, Turning a blind eye: The success of blinding reported in a random sample of randomised, placebo controlled trials. BMJ., 328, 2004, 432.
31. Zhao, YY, Yang, L, Deng, TT, Modern view on syndrome differentiation and treatment and concept of wholism. Chinese J Basic Med Traditional Chinese Med. 13 (2007), 481–484.
32. Zhang, JC, Chen, KJ, Combined disease with syndrome: Clinical optimization mode of integrated Chinese and Western medicine. World Chinese Med. 11 (2006), 14–15.
33. Stegemann, S, Bornem, C, Hard gelatin capsules today—and tomorrow. Capsugel Library, 1999, 1–23.
34. Williams, JR, The Declaration of Helsinki and public health. Bull World Health Organ. 86 (2008), 650–652.
35. Smoak, R Jr, Placebo: Its action and place in health research today. Sci Eng Ethics. 10 (2004), 9–13.
36. Spier, RE, Placebo: Its action and place in health research today—summary and conclusions. Sci Eng Ethics. 10 (2004), 189–197.